In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Aims Sex differences in the long-term prognosis of heart failure (HF) remain controversial,
and there is a lack of comprehensive pooling of the sex differences in outcomes of HF. This …

BACKGROUND: The STRONG-HF trial (Safety, Tolerability and Efficacy of Up-Titration of
Guideline-Directed Medical Therapies for Acute Heart Failure) demonstrated substantial …

BACKGROUND: Guideline-directed medical therapies (GDMTs) are the mainstay of
treatment for heart failure with reduced ejection fraction (HFrEF), but they are underused …

Aims We analysed baseline characteristics and guideline‐directed medical therapy (GDMT)
use and decisions in the European Society of Cardiology (ESC) Heart Failure (HF) III …

HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report
from the Heart Failure Society of America HF STATS 2024: Heart Failure Epidemiology and …

Background Predicting the clinical trajectory of individual patients with implantable
cardioverter-defibrillators (ICDs) is essential to inform clinical care. Machine learning …

Heart failure (HF) is an important comorbidity for patients with ischemic stroke, present in
11%–18% of patients, and may also independently increase the risk of first-ever and …

Background There is evidence that heart failure with preserved ejection fraction (HFpEF)–
related hospitalizations are increasing in the United States. However, there is a lack of …

Despite the progress in the care of individuals with heart failure (HF), important sex
disparities in knowledge and management remain, covering all the aspects of the syndrome …